Complement receptors and the shaping of the natural antibody repertoire

Springer Seminars in Immunopathology

Volumn 26, Issue 4, 2005, Pages 405-423

  Holers, V Michael ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Antibody repertoire; Autoimmunity; Complement activation; Complement receptors; Natural antibodies

Indexed keywords

ANTIBODY; AUTOANTIBODY; CELL NUCLEUS ANTIGEN; COMPLEMENT COMPONENT C2; COMPLEMENT RECEPTOR; DOUBLE STRANDED DNA;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN ANTIBODY COMPLEX; AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; CELL LINEAGE; CELLULAR IMMUNITY; CHROMATIN; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; EXPERIMENTAL MOUSE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSCRIPTION REGULATION;

ANIMALS; ANTIBODY FORMATION; AUTOIMMUNITY; B-LYMPHOCYTES; COMPLEMENT ACTIVATION; HUMANS; IMMUNITY, NATURAL; MICE; MODELS, IMMUNOLOGICAL; RECEPTORS, COMPLEMENT; RECEPTORS, COMPLEMENT 3D; T-LYMPHOCYTES;

EID: 16344371132     PISSN: 03444325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00281-004-0186-y     Document Type: Review

References (144)

1. Ahearn JM, Fearon DT (1989) Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21). Adv Immunol 46:183
2. Ahearn JM, Fischer MB, Croix DA, et al (1996) Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 4:251
3. Ascherio A, Munch M (2000) Epstein-Barr virus and multiple sclerosis. Epidemiology 11:220
4. Aubry JP, Pochon S, Gauchat JF, et al (1994) CD23 interacts with a new functional extracytoplasmic domain involving N-linked oligosaccharides on CD21. J Immunol 152:5806
5. Aubry JP, Pochon S, Graber P, et al (1992) CD21 is a ligand for CD23 and regulates IgE production. Nature 358:505
6. Bacon K, Gauchat JF, Aubry JP, et al (1993) CD21 expressed on basophilic cells is involved in histamine release triggered by CD23 and anti-CD21 antibodies. Eur J Immunol 23:2721
7. Baechler EC, Batliwalla FM, Karypis G, et al (2003) Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Nat Acad Sci USA 100:2610
8. Baumgarth N, Herman OC, Jager GC, et al (2000) B-1 and B-2 cell-derived immunoglobulin M anti-bodies are nonredundant components of the protective response to influenza virus. J Exp Med 192:271
9. Bjork P, Elenstrom-Magnusson C, Rosen A, et al (1993) CD23 and CD21 function as adhesion molecules in homotypic aggregation of human B lymphocytes. Eur J Immunol 23:1771
10. Boackle SA, Culhane KK, Brown JM, et al (2004) CR1/CR2 deficiency alters IgG3 autoantibody production and IgA glomerular deposition in the MRL/lpr model of SLE. Autoimmunity 37:111
11. Boackle SA, Holers VM, Chen X, et al (2001) Cr2, a candidate gene in the murine Sle 1c lupus susceptibility locus, encodes a dysfunctional protein. Immunity 15:775
12. Boackle SA, Morris MA, Holers VM, et al (1998) Complement opsonization is required for presentation of immune complexes by resting peripheral blood B cells. J Immunol 161:6537
13. Boes M, Prodeus AP, Schmidt T, et al (1998) A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J Exp Med 188:2381
14. Bohnsack JF, Cooper NR (1988) CR2 ligands modulate human B cell activation. J Immunol 141:2569
15. Bonnefoy JY, Henchoz S, Hardie D, et al (1993) A subset of anti-CD21 antibodies promote the rescue of germinal center B cells from apoptosis. Eur J Immunol 23:969
16. Bradbury LE, Kansas GS, Levy S, et al (1992) The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J Immunol 149:2841
17. Bradt BM, Kolb WP, Cooper NR (1998) Complement-dependent proinflammatory properties of the Alzheimer's disease beta-peptide. J Exp Med 188:431
18. Brown EJ (1991) Complement receptors and phagocytosis. Curr Opin Immunol 3:76
19. Cambier JC, Pleiman CM, Clark MR (1994) Signal transduction by the B cell antigen receptor and its coreceptors. Annu Rev Immunol 12:457
20. Carroll MC (1998) The role of complement and complement receptors in the induction and regulation of immunity. Annu Rev Immunol 16:545
21. Carroll MC (2000) The role of complement in B cell activation and tolerance. Adv Immunol 74:61
22. Carter RH, Fearon DT (1989) Polymeric C3dg primes human B lymphocytes for proliferation induced by anti-IgM. J Immunol 143:1755
23. Carter RH, Fearon DT (1992) CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256:105
24. Carter RH, Spycher MO, Ng YC, et al (1998) Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. J Immunol 141:457
25. Casali P, Schettino EW (1996) Structure and function of natural antibodies. Curr Top Microbiol Immunol 210:167
26. -/- mice: enhanced affinity maturation but impaired antibody persistence. J Immunol 164:4522
27. Cherukuru A, Pierce SK (2001) The role of the CD19/CD21 complex in B cell processing and presentation of complement-tagged antigens. J Immunol 167:172
28. Cohen JI (2000) Epstein-Barr virus infection. N Engl J Med 343:481
29. Collard CD, Agah A, Stahl GL (1998) Complement activation following reoxygenation of hypoxic human endothelial cells: role of intracellular reactive oxygen species, NF-kappaB and new protein synthesis. Immunopharmacology 39:39
30. Cooper NR, Moore MD, Nemerow GR (1988) Immunobiology of CR2, the B lymphocyte receptor for Epstein-Barr virus and the C3d complement fragment. Annu Rev Immunol 6:85
31. Croix AD, Ahearn JM, Rosengard AM, et al (1996) Antibody response to a T-dependent antigen requires B cell expression of complement receptors. J Exp Med 183:1857
32. Delcayre AX, Salas F, Mathur S, et al (1991) Epstein-Barr virus/complement C3d receptor is an interferon-α receptor. EMBO J 10:919
33. Dempsey PW, Allison ME, Akkaraju S, et al (1996) C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271:348
34. Fagarasan S, Kinoshita K, Muramatsu M, et al (2001) In situ class switching and differentiation of IgA-producing cells in the gut lamina propria. Nature 413:639
35. Fang Y, Xu C, Fu Y-X, et al (1998) Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response. J Immunol 160:5273
36. Fearon DT, Carter RH (1995) The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Annu Rev Immunol 13:127
37. Fearon DT, Locksley RM (1996) The instructive role of innate immunity in the acquired immune response. Science 272:50
38. Fingeroth JD, Weis JJ, Tedder TF, et al (1984) Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci USA 81:4510
39. Fischer E, Delibrias C, Kazatchkine MD (1991) Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes. J Immunol 146:865
40. Fischer MB, Goerg S, Shen L, et al (1998) Dependence of germinal center B cells on expression of CD21/CD35 for survival. Science 280, 582
41. Fleming SD, Shea-Donohue T, Guthridge JM, et al (2002) Mice deficient in complement receptors 1 and 2 lack a tissue injury-inducing subset of the natural antibody repertoire. J Immunol 169:2126
42. Fleming SD, Tsokos GC (2004) Autoimmunity, complement activation, tissue injury and reciprocal effects. Curr Dir Autoimmunity 7:149
43. Fujisaku A, Harley JB, Frank MB, et al (1989) Genomic organization and polymorphisms of the human C3d/Epstein- Barr virus receptor. J Biol Chem 264:2118
44. Gewurz H, Zhang X-H, Lint TF (1996) Structure and function of the pentraxins. Curr Opin Immunol 7:54
45. Girardi G, Berman J, Redecha P, et al (2003) Complement C5a receptors and neutrophils, but not activating Fcγ receptors, are critical mediators of anti-phospholipid antibody-induced fetal loss. J Clin Invest 112:1644
46. Gommerman JL, Oh DY, Zhou X, et al (2000) A role for CD21/CD35 and CD19 in responses to acute septic peritonitis: a potential mechanism for mast cell activation. J Immunol 165:6915
47. + T cell clones. Eur J Immunol 24:2982
48. Grossman J, Maxson JM, Whitacre CM, et al (1998) New isolation technique to study apoptosis in human intestinal epithelial cells. Am J Pathol 153:53
49. Guinamard R, Okigaki M, Schlessinger J, et al (2000) Absence of marginal zone B cells in Pyk-2 deficient mice defines their role in the humoral response. Nat Immunol 1:31
50. Haas KM, Hasegawa M, Steeber DA, et al (2002) Complement receptors CD21/35 link innate and protective immunity during Streptococcus phenumoniae infection by regulating IgG3 antibody responses. Immunity 17:713
51. Hagman J, Lo D, Doglio LT, et al (1989) Inhibition of immunoglobulin gene rearrangement by the expression of a 12 transgene. J Exp Med 169:1911
52. Hardy RR, Hayakawa K (2001) B cell development pathways. Annu Rev Immunol 19:595
53. Hasegawa M, Fujimoto M, Poe JC, et al (2001) CD19 can regulate B lymphocyte signal transduction independent of complement activation. J Immunol 167:3190
54. Henson SE, Smith D, Boackle SA, et al (2001) Generation of recombinant human C3dg tetramers for the analysis of CD21 binding and function. J Immunol Methods 258:97
55. Herzenberg LA (2000) B1 cells: the lineage question revisited. Immunol Rev 175:9
56. Holers VM (2001) Complement. In Rich R (ed) Principles and practices of clinical immunology. Mosby, St. Louis, pp 211-218
57. Holers VM, Boackle SA (2004) Complement receptor 2 and autoimmunity. Curr Dir Autoimmun 7:33
58. Holers VM, Thurman JM (2004) The alternative pathway of complement in disease: opportunities for therapeutic targeting. Mol Immunol 41:147
59. Holguin MH, Kurtz CB, Parker CJ, et al (1990) Loss of human CR1- and murine Crry-like exons in human CR2 transcripts due to CR2 gene mutations. J Immunol 145:1776
60. Hourcade D, Holers VM, Atkinson JP (1989) The regulators of complement activation (RCA) gene cluster. Adv Immunol 45:381
61. Hu H, Martin BK, Weis JJ, et al (1997) Expression of the murine CD21 gene is regulated by promoter and intronic sequences. J Immunol 158:4758
62. Huemer HP, Larcher C, Prodinger WM, et al (1995) Determination of soluble CD21 as a parameter of B cell activation. Clin Exp Immunol 93:195
63. Hunyadi J, Simon M, Kenderessy AS, et al (1991) Expression of complement receptor 2 (CD21) on human subcorneal keratinocytes in normal and diseased skin. Dermatologica 183:184
64. Iida K, Nadler L, Nussenzweig V (1983) Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody. J Exp Med 158:1021
65. Ikeda H, Suzuki Y, Suzuki M, et al (1998) Apoptosis is a major mode of cell death caused by ischaemia and ischaemia/reperfusion injury to the rat intestinal epithelium. Gut 42:530
66. James JA, James J, Neas BR, et al (2001) Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheum 44:1122
67. James, JA, Kaufman KM, Farris AD, et al (1998) An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J Clin Invest 100:3019
68. Kang I, Quan T, Nolasco H, et al (2004) Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus. J Immunol 172:1287
69. Kaya Z, Afanasyeva M, Wang Y, et al (2001) Contribution of the innate immune system to autoimmune myocarditis: a role for complement. Nat Immunol 2:739
70. Kim SJ, Gershov D, Ma X, et al (2002) I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation. J Exp Med 196:655
71. Kim YU, Kinoshita T, Molina H, et al (1995) Mouse complement regulatory protein Crry/p65 utilizes the specific mechanisms of both decay-accelerating factor and membrane cofactor protein. J Exp Med 181:151
72. Kirkitadze MD, Barlow PN (2001) Structure and flexibility of the multiple domain proteins that regulate complement activation. Immunol Rev 180:146
73. Kozono Y, Duke RC, Schleicher MS, et al (1995) Co-ligation of mouse complement receptors 1 and 2 with surface IgM rescues splenic B cells and WEHI-231 cells from anti-surface IgM-induced apoptosis. Eur J Immunol 25:1013
74. Kuppers R, Rajewsky K (1998) The origin of Hodgkin and Reed/Sternberg cells in Hodgkin's disease. Annu Rev Immunol 16:471
75. Kurtz CB, O'Toole E, Christensen SM, et al (1990) The murine complement receptor gene family. IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1. J Immunol 144:3581
76. Lambris JD, Sahu, Lambri A (2001) Structure and biology of complement protein C3, a connecting link between innate and acquired immunity. Immunol Rev 180:35
77. Levine J, Pflugfelder SC, Yen M, et al (1990) Detection of the complement (CD21)/Epstein-Barr virus receptor in human lacrimal gland and ocular surface epithelia. Reg Immunol 3:164
78. Levy E, Ambrus J, Kahl L, et al (1992) T lymphocyte expression of complement receptor 2 (CR2/ CD21): a role in adhesive cell-cell interactions and dysregulation in a patient with systemic lupus erythematosus (SLE). Clin Exp Immunol 90:235
79. Li X, Carter RH (2000) Systematic analysis of the role of CD19 cytoplasmic tyrosines in enhancement of activation in Daudi human B cells: clustering of phospholipase C and Vav and of Grb2 and Sos with different CD19 tyrosines. J Immunol 164:3123
80. Liszewski MK, Farries TC, Lublin DM, et al (1996) Control of the complement system. Adv Immunol 61:201
81. Loder F, Mutschler B, Ray RJ, et al (1999) B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J Exp Med 190:75
82. Lucas KG, Pollock KE, Emanuel DJ (1997) Post-transplant EBV induced lymphoproliferative disorders. Leuk Lymphoma 25:1
83. Luxembourg AT, Cooper NR (1994) Modulation of signaling via the B cell antigen receptor by CD21, the recptor for C3dg and EBV. J Immunol 153:4448
84. Lyons SF, Liebowitz DN (1998) The roles of human viruses in the pathogenesis of lymphoma. Semin Oncol 25:461
85. Makar KW, Pham CTN, Dehoff MH, et al (1998) An intronic silencer regulates B lymphocyte cell-and stage-specific expression of the human complement receptor type 2 (CR2, CD21) gene. J Immunol 160:1268
86. Makar KW, Ulgiati D, Hagman J, et al (2001) A site in the complement receptor 2 (CR2/CD21) silencer is necessary for lineage specific transcriptional regulation. Int Immunol 13:657
87. Marchbank KJ, Kulik L, Gipson MG, et al (2002) Expression of human complement receptor type 2 (CR2/CD21) in mice during early B cell development results in a reduction in mature B cells and hypogammaglobulinemia. J Immunol 169:3526
88. -/- mice restores humoral immune function. J Immunol 165:1354
89. Martin F, Kearney JF (2000) Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19 and btk. Immunity 12:39
90. Martin F, Kearney JF (2000) B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a "natural immune memory". Immunol Rev 175:70
91. Martin, F, Kearney JF (2001) B1 cells: similarities and differences with other B cell subsets. Curr Opin Immunol 13:195
92. Martin F, Oliver AM, Kearney JF (2001) Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 14:617
93. Matsumoto AK, Kopicky-Burd J, Carter RH, et al (1991) Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19. J Exp Med 173:55
94. Melamed D, Benschop RJ, Cambier JC, et al (1998) Developmental regulation of B lymphocyte immune tolerance compartmentalizes clonal selection from receptor selection. Cell 92:173
95. Mitchell DA, Pickering MC, Warren J, et al (2002) C1q deficiency and autoimmunity: the effects of genetic background on disease expression. J Immunol 168:2538
96. Molina H, Holers VM, Li B, et al (1996) Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc Natl Acad Sci USA 93:3357
97. Molina H, Kinoshita T, Inoue K, et al (1990) A molecular and immunochemical characterization of mouse CR2: evidence for a single gene model of mouse complement receptors 1 and 2. J Immunol 145:2974
98. Moore MD, Cooper NR, Tack BF, et al (1987) Molecular cloning of the cDNA encoding the Epstein-Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytes. Proc Natl Acad Sci USA 84:9194
99. Morel L, Blenman KR, Croker BP, et al (2001) The major murine SLE-susceptibility locus, Sle 1, is a cluster of functionally related genes. Proc Natl Acad Sci USA 98:1787
100. Muller-Eberhard HJ (1988) Molecular organization and function of the complement system. Annu Rev Biochem 57:321
101. Navratil JS, Watkins SC, Wisnieski JJ, et al (2001) The globular heads of C1q specifically recognize surface blebs of apoptotic vascular endothelial cells. J Immunol 166:3231
102. Nemerow GR, Houghten RA, Moore MD, et al (1989) Identification of an epitope in the major envelope protein of Epstein-Barr virus that mediates viral binding to the B lymphocyte EBV receptor (CR2). Cell 56:369
103. Nemerow GR, Wolfert R, McNaughton ME, et al (1985) Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2). J Virol 55:347
104. Ochsenbein AF, Fehr T, Lutz C, et al (1999) Control of early viral and bacterial distribution and disease by natural antibodies. Science 286:2156
105. Okano M (1998) Epstein-Barr virus infection and its role in the expanding spectrum of human diseases. Acta Paediatr 87:11
106. Paul E, Pozdnyakova OO, Mitchell E, et al (2002) Anti-DNA autoreactivity in C4-deficient mice. Eur J Immunol 32:2672
107. Pratt JR, Basheer SA, Sacks SH (2002) Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med 8:582
108. Prodeus A, Goerg S, Shen L-M, et al (1998) A critical role for complement in maintenance of self-tolerance. Immunity 9:721
109. Raab-Traub N (1992) Epstein-Barr virus and nasopharyngeal carcinoma. Semin Cancer Biol 3:297
110. Reid KBM, Turner MW (1994) Mammalian lectins in activation and clearance mechanisms involving the complement system. Springer Semin Immunopathol 15:307
111. Reid RR, Prodeus AP, Khan W, et al (1997) Endotoxin shock in antibody-deficient mice: unraveling the role of natural antibody and complement in the clearance of lipopolysaccharide. J Immunol 159:970
112. Reid RR, Woodstock S, Shimabukuro-Vornhagen A, et al (2002) Functional activity of natural antibody is altered in Cr2-deficient mice. J Immunol 169:5433
113. Reynes M, Aubert JP, Cohen JHM, et al (1985) Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigens. J Immunol 135:2687
114. Richards A, Goodship JA, Goodship TH (2002) The genetics and pathogenesis of haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura. Curr Opin Nephrol Hypertens 11:431
115. Richards A, Kemp EJ, Liszewski MK, et al (2003) Mutations in human complement regulator, membrane cotactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proc Natl Acad Sci USA 100:12966
116. Roudier J, Petersen J, Rhodes GH, et al (1989) Susceptibility to rheumatoid arthritis maps to a T-cell epitope sharedby the HLA-Dw4 DR β-1 chain and the Epstein-Barr virus glycoprotein gp110. Proc Natl Acad Sci USA 86:5104
117. Schaapherder AF, Gooszen HG, Bulte MT te, et al (1995) Human complement activation via the alternative pathway on porcine endothelium initiated by IgA antibodies. Tranplantation 60:287
118. Shaw PX, Horkko S, Chang M-K, et al (2000) Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest 105:1731
119. Shen Y, Lue L, Yang L, et al (2001) Complement activation by neurofibrillary tangles in Alzheimer's disease. Neurosci Lett 305:165
120. Strater J, Wedding U, Barth TFE, et al (1996) Rapid onset of apoptosis in vitro follow disruption of B1-integrin/matrix interactions in human colonie crypt cells. Gastroenterology 110:1776
121. Szakonyi G, Guthridge JM, Li D, et al (2001) Structure of complement receptor 2 in complex with its C3d ligand. Science 292:1725
122. Takahashi K, Kozono Y, Waldschmidt TJ, et al (1997) Mouse complement receptors type 1 (CR1; CD35) and type 2 (CR2; CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice. J Immunol 159:1557
123. Tedder TF, Clement LT, Cooper MD (1984) Expression of C3d receptors during human B cell differentiation: immunofluorescence analysis with the HB-5 monoclonal antibody. J Immunol 133:678
124. Tedder TF, Zhou LJ, Engel P (1994) The CD19/CD21 signal transduction complex of B lymphocytes. Immunol Today 15:437
125. Thornton BP, Vetvicka V, Ross GD (1994) Natural antibody and complement-mediated antigen processing and presentation by B lymphocytes. J Immunol 152:1727
126. Tolnay M, Tsokos GC (1998) Complement receptor 2 in the regulation of the immune response. Clin Immunol Immunopathol 88:123
127. Tolnay M, Vereshchagina LA, Tsokos GC (1999) Heterogeneous nuclear ribonucleoprotein DOE is a sequence-specific DNA-binding protein. Biochem J 338:417
128. Tolnay M, Vereshchagina LA, Tsokos GC (2002) NF-kappaB regulates the expression of the human complement receptor 2 gene. J Immunol 169:6236
129. Tsoukas CD, Lambris JD (1988) Expression of CR2/EBV receptors on human thymocytes detected by monoclonal antibodies. Eur J Immunol 18:1299
130. Turner MW, Hamvas RM (2000) Mannose-binding lectin: targeting the microbial world for complement attack and opsonophagocytosis. Rev Immunogenet 2:303
131. Ulgiati D, Holers VM (2001) CR2/CD21 proximal promoter activity is critically dependent on a cell type specific repressor. J Immunol 167:6912
132. Ulgiati D, Holers VM (2002) Functional analysis of the human CR2/CD21 promoter: characterization of basal transcriptional mechanisms. J Immunol 168:6279
133. Watry D, Hedrick JA, Siervo S, et al (1991) Infection of human thymocytes by Epstein-Barr virus. J Exp Med 173:971
134. Weis JJ, Fearon DT, Klickstein LB, et al (1986) Identification of a partial cDNA clone for the C3d/Epstein-Barr virus receptor of human B lymphocytes: homology with the receptor for fragments C3b and C4b of the third and fourth components of complement. Proc Natl Acad Sci USA 83:5639
135. r membrane protein as the C3d receptor (CR2) of human B lymphocytes. Proc Natl Acad Sci USA 81:881
136. Weis JJ, Toothaker LE, Smith JA, et al (1988) Structure of the human B lymphocyte receptor for C3d and the Epstein-Barr virus and relatedness to other members of the family of C3/C4 binding proteins. J Exp Med 167:1047
137. Weiser MR, Williams JP Jr, Moore FD, et al (1996) Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J Exp Med 183:2343
138. Wetsel RA (1995) Structure, function and cellular expression of complement anaphylatoxin receptors. Curr Opin Immunol 7:48
139. Wilson JG, Ratnoff WD, Schur PH, et al (1986) Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus. Arthritis Rheum 29:739
140. Wong NK, Kojima M, Dobo J, et al (1999) Activities of the MBL-associated serine proteases (MASPs) and their regulation by natural inhibitors. Mol Immunol 36:853
141. Wu X, Jiang N, Deppong C, et al (2002) A role for the Cr2 gene in modifying autoantibody production in systemic lupus erythematosus. J Immunol 169:1587
142. -/- mice is rescued by adjuvants without improvement in germinal center development. J Immunol 165:3119
143. Zabel MD, Byrne BL, Weis JJ, et al (2000) Cell-specific expression of the murine CD21 gene depends on accessibility of promoter and intronic elements. J Immunol 165:4437
144. Zhang M, Austen WG Jr, Chiu I, et al (2004) Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury. Proc Natl Acad Sci USA 101:3886